News from oncosec medical incorporated

Mar 25, 2013, 06:07 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical Updates Analysis of Interim Data for Phase II Study of ImmunoPulse in Metastatic Melanoma Patients

 OncoSec Medical Inc. (OTCQB: ONCS) – a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy...

Feb 06, 2013, 06:00 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical to Present at the 15th Annual BIO CEO & Investor Conference

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Jan 17, 2013, 06:08 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical to Present at Noble Financial Capital Markets' Ninth Annual Equity Conference on January 22

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Jan 15, 2013, 06:08 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical Announces 2013 Milestones and Corporate Strategy

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Dec 13, 2012, 09:30 ET
OncoSec Medical is focused on pursuing new business opportunities in the biomedical field.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical Announces $7.2 Million Public Offering

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Dec 04, 2012, 06:08 ET
OncoSec Medical is focused on pursuing new business opportunities in the biomedical field.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical to Present Data at DNA Vaccines 2012 Conference

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Nov 27, 2012, 06:08 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical to Present at NYSSA Life Sciences and LD Micro Investor Conferences

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Oct 23, 2012, 06:07 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical Incorporated Reports Positive Preliminary Efficacy and Safety Results from Phase II Study of ImmunoPulse in Merkel Cell Carcinoma Patients

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapies to...

Oct 17, 2012, 06:07 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Receives CE Mark for Its Electroporation Device

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse drug-based...

Oct 02, 2012, 06:09 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical to Present at 3rd Annual Cancer Immunotherapy Conference

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapies to treat...

Sep 05, 2012, 06:04 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Granted New Patent from China

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse and NeoPulse technologies to treat solid tumor cancers,...

Jul 11, 2012, 06:17 ET
OncoSec Medical is focused on pursuing new business opportunities in the biomedical field.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)

OncoSec Medical Inc. (OTCBB:ONCS), a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid...

Jul 09, 2012, 06:07 ET
OncoSec Medical is focused on pursuing new business opportunities in the biomedical field.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Initiates Phase II Clinical Program in Cutaneous T-Cell Lymphoma and Doses First Patient

SAN DIEGO, July 9, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing the advanced-stage OncoSec Medical System...

Jun 14, 2012, 06:05 ET
OncoSec Medical is focused on pursuing new business opportunities in the biomedical field.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec to Present at Upcoming Investor and Scientific Conferences

OncoSec Medical Inc. (OTCBB:ONCS), a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid...

Jun 05, 2012, 06:01 ET
OncoSec Medical is focused on pursuing new business opportunities in the biomedical field.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical Inc. Enters Into Exclusive Manufacturing Agreement with VGXI Inc. for Production of Interleukin-12 Plasmid DNA

OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid...

May 29, 2012, 06:01 ET
OncoSec Medical is focused on pursuing new business opportunities in the biomedical field.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec to Present at BioFinance 2012

OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid...

May 29, 2012, 06:01 ET
OncoSec Medical is focused on pursuing new business opportunities in the biomedical field.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical Issues Letter to Shareholders

 OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat...

Apr 23, 2012, 06:01 ET
OncoSec Medical is focused on pursuing new business opportunities in the biomedical field.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer

OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid...

Mar 28, 2012, 10:58 ET
OncoSec Medical is focused on pursuing new business opportunities in the biomedical field.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Closes $7.75 Million Public Offering

OncoSec Medical Incorporated (OTCBB: ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat...

Mar 26, 2012, 06:01 ET
OncoSec Medical is focused on pursuing new business opportunities in the biomedical field.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Announces $7.75 Million Public Offering

 OncoSec Medical Incorporated (OTCBB: ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge